Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SRPT
#1990
Sarepta Therapeutics, Inc. - Common Stock
18.8
2
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.69%
Monthly Change
+20.03%
6 month change
-16.98%
Year Change
-3.59%
Previous Close
18.9
5
Open
18.8
2
Low
18.8
2
High
18.8
2
Volume
196
Markets
US Stock Market
Healthcare
Biotechnology
SRPT
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
79.42 M
87.15 M
87.98 M
93.86 M
97.03 M
104.99 M
105.58 M
Valuation ratios
Enterprise value
13.03 B
6.83 B
11.56 B
9.84 B
11.83 B
2.29 B
2.54 B
Price to earnings ratio
-23.98
-17.47
-15.55
-16.59
51.96
-3.02
-21.39
Price to sales ratio
24.61
10.43
11.72
7.15
6.9
0.98
1.02
Price to cash flow ratio
123.67
-16.51
-33.6
-17.74
-63.74
-10.49
10.51
Price to book ratio
17.45
7.89
28.4
10.34
8.59
1.89
0.41
Enterprise value to EBITDA ratio
-24.25
-16.19
-23.39
-44.04
46.25
-3.49
608.67
Profitability ratios
Return on assets %
-0.19
-0.13
-0.22
-0.16
0.06
-0.21
0.1
Return on equity %
-0.73
-0.45
-1.83
-0.62
0.15
-0.63
0.22
Return on invested capital %
-387.46
-261.46
-324.22
-124.88
50.55
-160.7
70.5
Gross margin %
100
100
100
100
100
98.84
100
Operating margin %
-104.46
-65.5
-57.47
-21.54
11.47
-31.83
49.05
EBITDA margin %
-99.47
-60.08
-52.98
-17.97
13.45
-29.81
50.5
Net margin %
-102.6
-59.66
-75.4
-43.11
12.37
-32.45
45.29
Liquidity ratios
Quick ratio
5.42
5.34
3.8
3.45
3.18
1.48
2.62
Current ratio
5.97
5.75
4.13
3.95
4.2
2.32
4.63
Inventory turnover
—
—
—
—
—
0.18
0
Asset turnover
0.22
0.23
0.3
0.39
0.53
0.6
0.22
Solvency ratios
Debt to assets ratio
0.33
0.35
0.49
0.38
0.29
0.25
0.26
Debt to equity ratio
1.3
1.18
4.01
1.44
0.74
0.73
0.56
Long term debt to total assets ratio
0.38
0.36
0.49
0.38
0.29
0.25
0.26
Long term debt to total equity ratio
1.47
1.21
4.01
1.44
0.74
0.73
0.56
Per share metrics
Operating cash flow per share
1.38
-5.45
-3.72
-5.42
-1.91
-2.05
1.95
EBIT per share
-7.24
-5.66
-6.12
-2.9
2.02
-6.99
-1.12
EBITDA per share
-6.89
-5.19
-5.65
-2.42
2.37
-6.54
-0.69
Total debt per share
12.73
13.5
17.64
13.4
10.54
8.28
6.87
Cash per share
24.99
26.16
22.94
18.31
12.56
9.39
5.36
Net current asset value per share
31.88
32.05
29.21
27.92
28.49
25.35
18.95
Tangible book value per share
9.77
11.42
4.4
9.3
14.16
11.39
12.35
Working capital per share
26.54
26.47
22.14
20.84
21.71
14.41
14.85
Book value per share
9.77
11.42
4.4
9.3
14.16
11.39
12.35
News
SRPT or PRTA: Which Is the Better Value Stock Right Now?
Sarepta: Caution Still Warranted Despite FDA's Gene Therapy Friendly Stance (NASDAQ:SRPT)
All You Need to Know About Sarepta Therapeutics (SRPT) Rating Upgrade to Buy
SRPT vs. ARGX: Which Stock Is the Better Value Option?
Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report?
KROS Turns to Next Wave of TGF-Beta Muscle Therapies
KROS Turns to Next Wave of TGF-Beta Muscle Therapies
Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
Should You Buy KROS After Q1 Miss and Takeda Deal Reset?
KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
KROS Stock Guide to Rinvatercept in DMD and ALS for 2026
Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review